Abstract
Four stereoisomers of 2-norbornyl-N–n-butylcarbamates are characterized as the pseudo substrate inhibitors of cholesterol esterase. Cholesterol esterase shows enantioselective inhibition for enantiomers of exo- and endo-2-norbornyl-N–n-butylcarbamates. For the inhibitions by (R)-(+)- and (S)-(−)-exo-2-norbornyl-N–n-butylcarbamates, the R-enantiomer is 6.8 times more potent than the S-enantiomer. For the inhibitions by (R)-(+)- and (S)-(−)-endo-2-norbornyl-N–n-butyl-carbamates, the S-enantiomer is 4.6 times more potent than the R-enantiomer. The enzyme-inhibitor complex models have been proposed to explain these different enantioselectivities.
Similar content being viewed by others
Abbreviations
- ACS:
-
Acyl chain binding site
- CEase:
-
Cholesterol esterase
- LDL:
-
Low-density lipoprotein
- PNPB:
-
p-nitrophenyl butyrate
- TX:
-
Triton-X 100
References
Auer J, Eber B (1999) J Clin Basic Cardiol 2:203–208
Berson JA, Walla JS, Remanick A, Suzuki S, Reynods-Warnhoff P, Willner D (1961) J Am Chem Soc 83:3986–3997
Brodt-Eppley J, White P, Jenkins S, Hui D (1995) Biochim Biophys Acta 1272:69–72
Chen JC-H, Miercke LJW, Krucinski J, Starr JR, Saenz G, Wang X, Spilburg CA, Lange LG, Ellsworth JL, Stroud RM (1998) Biochemistry 37:5107–5117
Chiou S-Y, Huang C-F, Yeh S-J, Chen I-R, Lin G (2010) J Enzym Inhib Med Chem 25:13–20
Chiou S-Y, Huang C-F, Yeh S-J, Chen I-R, Lin G (2010) Chirality 22:267–274
Chiou S-Y, Lai G-W, Lin L-Y, Lin G (2006) Ind J Biochem Biophys 43:52–55
Dale JA, Mosher HS (1973) J Am Chem Soc 95:512–519
Feaster SR, Quinn DM (1997) Meth Enzymol 286:231–252
Feaster SR, Lee K, Baker N, Hui DY, Quinn DM (1996) Biochemistry 35:16723–16734
Hosie L, Sutton LD, Quinn DM (1987) J Biol Chem 262:260–264
Hui DY (1996) Biochim Biophys Acta 1302:1–14
Irwin AJ, Jones JB (1976) J Am Chem Soc 98:8476–8482
Lopez-Candales A, Bosner MS, Spilburg CA, Lange LG (1993) Biochemistry 32:12085–12089
Maron DJ, Fazio S, Linton MF (2000) Circulation 101:207–213
Nakazaki M, Chikamatsu H, Naemura K, Asao M (1980) J Org Chem 45:4432–4440
Pietsch M, Gütschow M (2002) J Biol Chem 277:24006–24013
Pietsch M, Gütschow M (2005) J Med Chem 48:8270–8288
Pioruńska-Stolzmann M, Piroruńska-Mikołajczak A (2002) Pharm Res 43:359–362
Takahashi T, Fukuishima A, Tanaka Y, Takeuchi Y, Kabuto K, Kabuto C (2000) Chem Commun 788–789
Takahashi T, Kameda H, Kamei T, Ishizaki M (2006) J Fluorine Chem 127:760–768
Wang C-S, Hartsuck JA (1993) Biochim Biophys Acta 1166:1–19
Wang X, Wang C-S, Tang J, Dyda F, Zhang XC (1997) Structure 5:1209–1218
Winstein S, Trifan D (1951) J Am Chem Soc 74:1154–1160
Yoshizako F, Nishimura A, Chubachi M, Kirihata M (1996) J Ferm Bioeng 82:601–603
Acknowledgments
We thank the National Science Council of Taiwan for financial support.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lin, MC., Yeh, SJ., Chen, IR. et al. Stereoselective Inhibition of Cholesterol Esterase by Enantiomers of exo- and endo-2-Norbornyl-N–n-butylcarbamates. Protein J 30, 220–227 (2011). https://doi.org/10.1007/s10930-011-9323-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10930-011-9323-3